UL vs ULS: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: UL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. UL and ULS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined UL and ULS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Unilever PLC is one of the world's largest consumer-goods companies, and UL is its NYSE-listed ADR (the London line trades as ULVR, with a further listing in Amsterdam). After the late-2025 demerger of its ice cream arm, Unilever is organized around four business groups: Beauty & Wellbeing (Dove, Vaseline, and premium and wellness brands), Personal Care (deodorants, skin cleansing, and oral care such as Rexona and Lifebuoy), Home Care (laundry and cleaning brands like Persil and Cif), and Foods, also called Nutrition (Knorr, Hellmann's, and cooking products). A large share of turnover now comes from a concentrated set of roughly 30 Power Brands, which the company reports have been growing faster than the overall portfolio. Because it sells low-cost, repeat-purchase essentials, Unilever tends to hold up better than cyclical businesses in downturns, though it is exposed to input-cost inflation, currency swings, and slower volume growth in developed markets.

Full UL guide

UL Solutions Inc. is a global safety-science company that traces its roots to Underwriters Laboratories, founded in 1894. It earns money by testing, inspecting and certifying products against safety and performance standards, most visibly through the UL mark found on consumer electronics, appliances, wiring and industrial equipment. The business runs across three segments: Industrial (energy, automation, engineered materials and the built environment), Consumer (electronics, medical devices, appliances, HVAC and lighting), and Software and Advisory (regulatory, supply-chain and sustainability tools). Much of the revenue is recurring, because certified products need ongoing follow-up testing to keep their marks, and the company remains majority controlled by the nonprofit UL Standards and Engagement following its April 2024 IPO.

Full ULS guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• UL drivers: Power Brands and premiumization; Growth Action Plan and cost discipline.
• ULS drivers: Regulation-driven recurring demand; Electrification and new technology testing.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. For ULS, the most cited risk is valuation: at a trailing P/E in the low 50s and a forward multiple well above the mid-teens typical of professional-services peers, the stock prices in continued strong execution and leaves little room for disappointment.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick UL if you believe its drivers more; ULS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the UL and ULS guides.

UL. Figures are qualitative and tied to the asOf date; verify live numbers before acting. Unilever is valued as a stable, cash-generative consumer staple rather than a fast grower, so its multiple hinges on whether the Growth Action Plan can lift volume growth and margins. Because it is an ADR of a euro-reporting company, currency moves affect the dollar figures US investors see, including the dividend, independent of how the underlying business performs.

ULS. FY2025 revenue rose about 6.4% to roughly $3.05 billion, while net income was about flat near $325 million and EPS was roughly $1.62. The market capitalization of about $17.8 billion in April 2026 is up more than 200% from the roughly $5.76 billion implied at the April 2024 IPO. The resulting trailing P/E in the low 50s sits far above the mid-teens average for professional-services peers, reflecting the premium investors assign to the brand and recurring model.

Headline figures (approximate, Jul 2026): UL shows business mix Four business groups after the ice cream demerger: Beauty & Wellbeing, Personal Care, Home Care, and Foods (Nutrition); verify live figures before acting, revenue scale Tens of billions of euros in annual turnover (reported in euros; UL is a dollar-denominated ADR), spread across roughly 190 countries; verify live figures before acting, underlying sales growth Mid-single-digit percentage in recent periods, led by Power Brands and beauty/personal care; verify the latest quarter before acting, dividend Pays a quarterly dividend and is widely held as a defensive income stock; treat any specific yield as a live figure to confirm before acting; ULS shows revenue (fy2025) ~$3.05B, revenue growth (fy2025) ~6.4%, net income (fy2025) ~$325M, diluted eps (fy2025) ~$1.62.

UL and ULS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined UL and ULS exposure against your real portfolio. It is not an investment adviser.